Search

everythinglearnresearchcommunity

for

Search:↓

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

OM-X® helped prevent negative effects of Vitamin C deficiency in mice, suggesting it could protect organs and regulate metabolism.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

MK-5108 is safe and shows potential against tumors, especially alone.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

TAK-279 effectively reduces psoriasis symptoms and is safe.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Booster doses of Covaxin improve protection against the Omicron variant.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Polygoni Multiflori Radix may help reduce skin aging by lowering collagenase and elastase activity.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

The solution increased hair density safely and effectively for hair loss.

Platelet-rich plasma therapy could be an effective treatment for melasma with minimal side effects.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Alpha-melanocyte-stimulating hormone helps manage skin inflammation and protect against UV damage.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.